Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Oct;74(4):1540–1544. doi: 10.1172/JCI111568

Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man.

N H Bell, S Shaw, R T Turner
PMCID: PMC425325  PMID: 6332830

Abstract

Previous in vitro studies in rachitic rat liver suggested that 1,25-dihydroxyvitamin D inhibits the hepatic production of 25-hydroxyvitamin D (25-OHD). An investigation therefore was carried out in eight normal subjects to determine whether concomitant administration of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] would alter the response of serum 25-OHD to challenge with vitamin D. In control studies, vitamin D, 100,000 U/d for 4 d, significantly increased mean serum 25-OHD, from 26.3 +/- 2.9 to 66.7 +/- 12.6 ng/ml (P less than 0.01). In contrast, 1,25(OH)2D3, 2 micrograms/d for 4 d, completely prevented an increase in serum 25-OHD in response to the same dose of vitamin D in the same individuals (25.1 +/- 2.2 vs. 27.4 +/- 5.3 ng/ml, NS). In a post-control study in seven of the normal subjects, vitamin D again significantly increased mean serum 25-OHD, from 18.2 +/- 3.1 to 42.8 +/- 4.7 ng/ml (P less than 0.001). In each of the three studies, mean serum calcium, phosphorus, and creatinine did not change and remained within the normal range. Whereas mean urinary calcium did not change in response to vitamin D alone during the 4 d of the two control studies, it increased significantly in the study in which vitamin D and 1,25(OH)2D3 were given together. A dose-response inhibition of the response of serum 25-OHD to vitamin D by 1,25(OH)2D3 was demonstrated in two of the normal subjects. The results provide evidence that 1,25(OH)2D3 inhibits the hepatic synthesis of its precursor 25-OHD in man.

Full text

PDF
1540

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. S., Sharma O. P., Gacad M. A., Singer F. R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest. 1983 Nov;72(5):1856–1860. doi: 10.1172/JCI111147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baginski E. S., Marie S. S., Clark W. L., Zak B. Direct microdetermination of serum calcium. Clin Chim Acta. 1973 Jun 14;46(1):49–54. doi: 10.1016/0009-8981(73)90101-0. [DOI] [PubMed] [Google Scholar]
  3. Baran D. T., Milne M. L. 1,25 dihydroxyvitamin D-induced inhibition of 3H-25 hydroxyvitamin D production by the rachitic rat liver in vitro. Calcif Tissue Int. 1983 Jul;35(4-5):461–464. doi: 10.1007/BF02405077. [DOI] [PubMed] [Google Scholar]
  4. Bartels H., Böhmer M. Eine Mikromethode zur Kreatininbestimmung. Clin Chim Acta. 1971 Mar;32(1):81–85. doi: 10.1016/0009-8981(71)90467-0. [DOI] [PubMed] [Google Scholar]
  5. Bell N. H., Stern P. H., Pantzer E., Sinha T. K., DeLuca H. F. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest. 1979 Jul;64(1):218–225. doi: 10.1172/JCI109442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Breslau N. A., McGuire J. L., Zerwekh J. E., Frenkel E. P., Pak C. Y. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med. 1984 Jan;100(1):1–6. doi: 10.7326/0003-4819-100-1-1. [DOI] [PubMed] [Google Scholar]
  7. Dorantes L. M., Arnaud S. B., Arnaud C. D. Importance of the isolation of 25-hydroxyvitamin D before assay. J Lab Clin Med. 1978 May;91(5):791–796. [PubMed] [Google Scholar]
  8. Haussler M. R., Baylink D. J., Hughes M. R., Brumbaugh P. F., Wergedal J. E., Shen F. H., Nielsen R. L., Counts S. J., Bursac K. M., McCain T. A. The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels. Clin Endocrinol (Oxf) 1976;5 (Suppl):151S–165S. doi: 10.1111/j.1365-2265.1976.tb03823.x. [DOI] [PubMed] [Google Scholar]
  9. Hughes M. R., Baylink D. J., Jones P. G., Haussler M. R. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest. 1976 Jul;58(1):61–70. doi: 10.1172/JCI108459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kantarjian H. M., Saad M. F., Estey E. H., Sellin R. V., Samaan N. A. Hypercalcemia in disseminated candidiasis. Am J Med. 1983 Apr;74(4):721–724. doi: 10.1016/0002-9343(83)91033-1. [DOI] [PubMed] [Google Scholar]
  11. Kaplan R. A., Haussler M. R., Deftos L. J., Bone H., Pak C. Y. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest. 1977 May;59(5):756–760. doi: 10.1172/JCI108696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lambert P. W., Hollis B. W., Bell N. H., Epstein S. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism. J Clin Invest. 1980 Oct;66(4):782–791. doi: 10.1172/JCI109916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Loré F., Di Cairano G., Periti P., Caniggia A. Effect of the administration of 1,25-dihydroxyvitamin D3 on serum levels of 25-hydroxyvitamin D in postmenopausal osteoporosis. Calcif Tissue Int. 1982;34(6):539–541. doi: 10.1007/BF02411300. [DOI] [PubMed] [Google Scholar]
  14. Mason R. S., Lissner D., Posen S., Norman A. W. Blood concentrations of dihydroxylated vitamin D metabolites after an oral dose. Br Med J. 1980 Feb 16;280(6212):449–450. doi: 10.1136/bmj.280.6212.449-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Norman D. A., Fordtran J. S., Brinkley L. J., Zerwekh J. E., Nicar M. J., Strowig S. M., Pak C. Y. Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest. 1981 Jun;67(6):1599–1603. doi: 10.1172/JCI110194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Papapoulos S. E., Clemens T. L., Fraher L. J., Lewin I. G., Sandler L. M., O'Riordan J. L. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet. 1979 Mar 24;1(8117):627–630. doi: 10.1016/s0140-6736(79)91076-6. [DOI] [PubMed] [Google Scholar]
  17. Prince M. J., Schaeffer P. C., Goldsmith R. S., Chausmer A. B. Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations. Ann Intern Med. 1982 May;96(5):586–591. doi: 10.7326/0003-4819-96-5-586. [DOI] [PubMed] [Google Scholar]
  18. Reinhardt T. A., Horst R. L., Orf J. W., Hollis B. W. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab. 1984 Jan;58(1):91–98. doi: 10.1210/jcem-58-1-91. [DOI] [PubMed] [Google Scholar]
  19. Stern P. H., De Olazabal J., Bell N. H. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest. 1980 Oct;66(4):852–855. doi: 10.1172/JCI109924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stern P. H., Taylor A. B., Bell N. H., Epstein S. Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children. J Clin Invest. 1981 Nov;68(5):1374–1377. doi: 10.1172/JCI110386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Streck W. F., Waterhouse C., Haddad J. G. Glucocorticoid effects in vitamin D intoxication. Arch Intern Med. 1979 Sep;139(9):974–977. [PubMed] [Google Scholar]
  22. Taylor A. B., Stern P. H., Bell N. H. Abnormal regulation of circulating 25-hydroxyvitamin D in the Williams syndrome. N Engl J Med. 1982 Apr 22;306(16):972–975. doi: 10.1056/NEJM198204223061607. [DOI] [PubMed] [Google Scholar]
  23. Zerwekh J. E., Glass K., Jowsey J., Pak C. Y. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 1979 Aug;49(2):171–175. doi: 10.1210/jcem-49-2-171. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES